LiverSource »  Faculty »  Program Leadership »  Francis Y.K. Yao, M.D.
Francis Y.K. Yao, M.D.

Francis Y.K. Yao, M.D.

Professor of Clinical Medicine and Surgery,
Departments of Medicine and Surgery
Medical Director, Liver Transplant Service
Director for Community Liaison, Liver Transplant Service

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 514-0332
Fax: 415-476-0659
Francis.yao@ucsf.edu
Open Popup
  • 1979-1980 University of San Francisco, Chemistry Major
  • 1980-1983 University of California, Berkeley B.S. Chemistry with High Honors
  • 1983-1987 Albert Einstein College of Medicine. M.D. Medicine
  • 1987-1988 Stanford University Hospital, Intern, Internal Medicine
  • 1988-1990 Stanford University Hospital, Resident, Internal Medicine
  • 1990-1993 Stanford University Hospital, Fellow, Gastroenterology
  • 1995 American Board of Internal Medicine - ABIM 147033 (Re-certification 2008)
  • 1997 American Board of Gastroenterology - ABIM 147033
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Transplant Program
  • UCSF Liver Center
  • Hepatitis in Asians
  • Liver Injury and Repair
  • Liver transplantation outcomes including expanded criteria liver transplants
  • Loco-regional therapy for hepatocellular carcinoma

Dr. Francis Yao is a gastroenterologist and medical director of the Liver Transplant Program at UCSF Medical Center. Dr. Yao is a professor of medicine in the UCSF School of Medicine. He also is director of UCSF's Liver Transplant Outreach and Community Liaison Program. In his research, he is interested in liver cancer treatment, particularly related to liver transplants, and has contributed to important publications in this area. His other research interests include hepatitis B infection and outcomes for liver transplantation.

Most recent publications from a total of 75
  1. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of Hepatocellular Carcinoma in Patients Receiving no Loco-regional Therapy Prior to Liver Transplant: An Analysis of the OPTN Explant Pathology Form. Clin Transplant. 2017 Sep 07. View in PubMed
  2. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 Sep; 101(9):2071-2078. View in PubMed
  3. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 Aug; 23(8):1015-1022. View in PubMed
  4. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 01; 3(4):493-500. View in PubMed
  5. Mehta N, Yao FY. Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)? Gastroenterology. 2016 Dec; 151(6):1062-1065. View in PubMed
  6. Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology. 2016 Oct; 64(4):1178-88. View in PubMed
  7. Mehta N, Yao FY. Reply. Liver Transpl. 2016 Aug; 22(8):1164-5. View in PubMed
  8. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9. View in PubMed
  9. Mehta N, Roberts JP, Yao FY. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver Transpl. 2016 05; 22(5):582-4. View in PubMed
  10. Mehta N, Yao FY. Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan. Curr Opin Organ Transplant. 2016 Apr; 21(2):91-8. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Francis Y.K. Yao, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X